Explore detailed financial insights for NSE: Wanbury Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Wanbury Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Wanbury, including updates on board meetings and corporate actions.

WANBURY
Wanbury Limited - https://www.wanbury.com
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Wanbury Limited Share Price Today

220.00
OPEN
228.15
HIGH
215.15
LOW
226.95
CLOSE
156 K
VOLUME
924 Cr
Market Cap
125619
Average Volume
Healthcare
Sector
NSI
Exchange

Wanbury Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: WANBURY Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Wanbury Limited
WANBURY
INE107F01022
Annual General Meeting
20 Sep 2024
10
N/A
Wanbury Limited
WANBURY
INE107F01022
Extra Ordinary General Meeting
10 Nov 2023
10
N/A
Wanbury Limited
WANBURY
INE107F01022
Annual General Meeting
20 Sep 2023
10
N/A
Wanbury Limited
WANBURY
INE107F01022
Extra-Ordinary General Meeting
14 Aug 2023
10
N/A
Wanbury Limited
WANBURY
INE107F01022
Annual General Meeting
20 Sep 2022
10
N/A

NSE: WANBURY Recent Announcements

Symbol
Date
Description
Industry
WANBURY
03 Jan 2025, 17:06:32
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pharmaceuticals
WANBURY
03 Jan 2025, 15:12:40
Updates
Pharmaceuticals
WANBURY
27 Dec 2024, 18:15:26
Trading Window-XBRL
Pharmaceuticals
WANBURY
27 Dec 2024, 18:11:29
Trading Window
Pharmaceuticals
WANBURY
20 Dec 2024, 11:58:02
Press Release
Pharmaceuticals

NSE: WANBURY Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Wanbury Limited
WANBURY
10 Jan 2025, 11:54:00
10 Jan 2025, 11:54:00
Wanbury Limited
WANBURY
16 Oct 2024, 18:59:00
16 Oct 2024, 18:59:00
Wanbury Limited
WANBURY
08 Nov 2024, 15:27:00
08 Nov 2024, 15:27:00
Wanbury Limited
WANBURY
17 Jul 2024, 16:14:00
17 Jul 2024, 16:14:00
Wanbury Limited
WANBURY
22 Apr 2024, 11:13:00
22 Apr 2024, 11:30:00

NSE: WANBURY Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson & Executive Director
01 Jan 1985
01 Sep 2010
00005868
CHANDRAN KRISHNAMOORTHY
Active
Executive Director
20 Jul 1958
21 Aug 2023
07878975
MOHAN KUMAR RAYANA
Active
Independent Director
04 Jan 1983
18 Nov 2023
10356479
PRAVIN DILIP PAWAR
Active
Independent Director
10 Oct 1975
17 Mar 2023
02713517
ANUPAMA VAIDYA
Active
Independent Director
16 Feb 1965
12 Aug 2024
10177545
MRIDUL SUMANLAL MEHTA
Active

NSE: WANBURY Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Board Meeting Intimation
WANBURY
N/A
INE107F01022
Wanbury Limited
05 Nov 2024, 19:05:22
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
WANBURY
N/A
INE107F01022
Wanbury Limited
06 Aug 2024, 11:05:54
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 16-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 .
WANBURY
N/A
INE107F01022
Wanbury Limited
07 May 2024, 18:28:56
Financial Results
WANBURY
N/A
INE107F01022
Wanbury Limited
12 Jan 2024, 15:20:03
Financial Results
WANBURY
N/A
INE107F01022
Wanbury Limited
12 Oct 2023, 16:44:03

NSE: WANBURY Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
WANBURY
-
INE107F01022
Wanbury Limited
05 Nov 2024, 00:00:00
To consider and approve the Un-audited financial results for the period ended September 30, 2024
Financial Results
WANBURY
-
INE107F01022
Wanbury Limited
06 Aug 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results
WANBURY
-
INE107F01022
Wanbury Limited
07 May 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024
Financial Results
WANBURY
-
INE107F01022
Wanbury Limited
12 Jan 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023
Financial Results
WANBURY
-
INE107F01022
Wanbury Limited
12 Oct 2023, 00:00:00
To consider and approve the financial results for the period ended September 30, 2023

NSE: WANBURY Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Minority Interest Stockholders Equity Other Equity Interest Fixed Assets Revaluation Reserve Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Non Current Pension And Other Postretirement Benefit Plans Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Available For Sale Securities Financial Assets Designatedas Fair Value Through Profitor Loss Long Term Equity Investment Investmentsin Subsidiariesat Cost Goodwill And Other Intangible Assets Other Intangible Assets Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Hedging Assets Current Assets Held For Sale Current Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 32,760,498.00 32,760,498.00 1,696,646,000.00 1,807,219,000.00 385,064,000.00 2,143,055,000.00 -304,065,000.00 385,064,000.00 51,626,000.00 387,462,000.00 1,574,962,000.00 387,462,000.00 0.00 387,462,000.00 59,857,000.00 0.00 0.00 0.00 327,605,000.00 327,605,000.00 3,580,302,000.00 1,379,822,000.00 0.00 1,208,734,000.00 21,234,000.00 1,187,500,000.00 171,088,000.00 2,200,480,000.00 82,897,000.00 0.00 598,485,000.00 30,392,000.00 568,093,000.00 0.00 34,752,000.00 1,376,266,000.00 0.00 0.00 1,376,266,000.00 3,967,764,000.00 2,071,349,000.00 131,242,000.00 0.00 55,000,000.00 61,572,000.00 61,572,000.00 0.00 0.00 0.00 2,398,000.00 2,398,000.00 1,808,935,000.00 0.00 1,808,935,000.00 157,950,000.00 1,650,985,000.00 0.00 0.00 0.00 0.00 1,896,415,000.00 267,579,000.00 0.00 0.00 0.00 0.00 376,337,000.00 0.00 0.00 0.00 0.00 0.00 0.00 1,114,933,000.00 0.00 0.00 137,566,000.00 78,619,000.00 58,947,000.00 0.00
2024-03-31T00:00:00 annual 32,745,498.00 32,745,498.00 1,065,518,000.00 1,164,846,000.00 276,754,000.00 1,378,934,000.00 -548,199,000.00 276,754,000.00 65,326,000.00 279,414,000.00 1,099,414,000.00 279,414,000.00 0.00 279,414,000.00 68,407,000.00 0.00 -1,385,022,000.00 1,024,991,000.00 327,455,000.00 327,455,000.00 3,155,517,000.00 1,014,460,000.00 155,141,000.00 859,319,000.00 39,319,000.00 820,000,000.00 155,141,000.00 2,141,057,000.00 119,726,000.00 0.00 305,527,000.00 26,007,000.00 279,520,000.00 30,406,000.00 30,406,000.00 1,777,293,000.00 149,803,000.00 0.00 1,627,490,000.00 3,434,931,000.00 1,843,043,000.00 8,141,000.00 34,774,000.00 55,000,000.00 255,000.00 69,380,000.00 255,000.00 0.00 0.00 2,660,000.00 2,660,000.00 1,704,743,000.00 -802,136,000.00 2,506,879,000.00 38,200,000.00 90,481,000.00 1,200,725,000.00 509,494,000.00 667,979,000.00 0.00 1,592,858,000.00 270,057,000.00 0.00 0.00 24,969,000.00 62,909,000.00 360,232,000.00 2,670,000.00 94,207,000.00 58,367,000.00 204,988,000.00 9,160,000.00 207,148,000.00 894,438,000.00 -24,533,000.00 918,971,000.00 34,002,000.00 34,129,000.00 34,002,000.00 34,002,000.00
2024-03-31T00:00:00 quarterly 32,745,498.00 32,745,498.00 1,065,518,000.00 1,164,846,000.00 276,754,000.00 1,378,934,000.00 -548,199,000.00 276,754,000.00 65,326,000.00 279,414,000.00 1,099,414,000.00 279,414,000.00 0.00 279,414,000.00 68,407,000.00 0.00 -1,385,022,000.00 1,024,991,000.00 327,455,000.00 327,455,000.00 3,155,517,000.00 1,014,460,000.00 155,141,000.00 859,319,000.00 39,319,000.00 820,000,000.00 155,141,000.00 2,141,057,000.00 119,726,000.00 0.00 305,527,000.00 26,007,000.00 279,520,000.00 30,406,000.00 30,406,000.00 1,777,293,000.00 149,803,000.00 0.00 1,627,490,000.00 3,434,931,000.00 1,843,043,000.00 8,141,000.00 34,774,000.00 55,000,000.00 255,000.00 69,380,000.00 255,000.00 0.00 0.00 2,660,000.00 2,660,000.00 1,704,743,000.00 -802,136,000.00 2,506,879,000.00 38,200,000.00 90,481,000.00 1,200,725,000.00 509,494,000.00 667,979,000.00 0.00 1,592,858,000.00 270,057,000.00 0.00 0.00 24,969,000.00 62,909,000.00 360,232,000.00 2,670,000.00 94,207,000.00 58,367,000.00 204,988,000.00 9,160,000.00 207,148,000.00 894,438,000.00 -24,533,000.00 918,971,000.00 34,002,000.00 34,129,000.00 34,002,000.00 34,002,000.00
2023-09-30T00:00:00 quarterly 32,735,498.00 32,735,498.00 983,859,000.00 1,133,878,000.00 -223,317,000.00 833,468,000.00 -976,168,000.00 -223,317,000.00 77,813,000.00 -222,597,000.00 727,403,000.00 -222,597,000.00 0.00 -222,597,000.00 -549,952,000.00 0.00 0.00 0.00 327,355,000.00 327,355,000.00 3,684,714,000.00 1,158,565,000.00 0.00 1,006,377,000.00 56,377,000.00 950,000,000.00 152,188,000.00 2,526,149,000.00 207,252,000.00 0.00 127,501,000.00 21,436,000.00 106,065,000.00 0.00 35,666,000.00 1,631,018,000.00 0.00 14,443,000.00 1,616,575,000.00 3,462,117,000.00 1,912,136,000.00 26,961,000.00 0.00 55,000,000.00 41,962,000.00 41,962,000.00 0.00 0.00 0.00 720,000.00 720,000.00 1,767,839,000.00 0.00 1,767,839,000.00 101,686,000.00 1,666,153,000.00 0.00 0.00 0.00 0.00 1,549,981,000.00 326,363,000.00 0.00 0.00 0.00 0.00 351,715,000.00 0.00 0.00 0.00 0.00 0.00 0.00 756,652,000.00 0.00 0.00 115,251,000.00 43,045,000.00 72,206,000.00 0.00
2023-03-31T00:00:00 annual 32,705,498.00 32,705,498.00 1,029,601,000.00 1,085,847,000.00 -329,046,000.00 716,382,000.00 -1,962,397,000.00 -329,046,000.00 41,303,000.00 -328,162,000.00 -328,162,000.00 -328,162,000.00 0.00 -328,162,000.00 16,312,000.00 1,173,000.00 -1,938,663,000.00 1,022,381,000.00 327,055,000.00 327,055,000.00 3,363,376,000.00 163,114,000.00 139,347,000.00 23,767,000.00 23,767,000.00 0.00 139,347,000.00 3,200,262,000.00 3,000.00 15,126,000.00 1,062,080,000.00 17,536,000.00 1,044,544,000.00 26,780,000.00 26,780,000.00 2,003,442,000.00 516,328,000.00 15,126,000.00 1,487,114,000.00 3,035,214,000.00 1,797,409,000.00 13,050,000.00 37,215,000.00 55,000,000.00 144,000.00 42,259,000.00 144,000.00 0.00 0.00 884,000.00 884,000.00 1,699,266,000.00 -708,510,000.00 2,407,776,000.00 29,108,000.00 78,100,000.00 1,126,460,000.00 575,127,000.00 598,981,000.00 0.00 1,237,865,000.00 273,881,000.00 147,000.00 19,654,000.00 24,375,000.00 60,040,000.00 219,874,000.00 2,131,000.00 58,356,000.00 55,307,000.00 104,080,000.00 18,578,000.00 190,452,000.00 689,802,000.00 -21,120,000.00 710,922,000.00 14,943,000.00 33,100,000.00 14,943,000.00 14,943,000.00
2023-03-31T00:00:00 quarterly 32,705,498.00 32,705,498.00 1,029,601,000.00 1,085,847,000.00 -329,046,000.00 716,382,000.00 -1,962,397,000.00 -329,046,000.00 41,303,000.00 -328,162,000.00 -328,162,000.00 -328,162,000.00 0.00 -328,162,000.00 16,312,000.00 1,173,000.00 -1,938,663,000.00 1,022,381,000.00 327,055,000.00 327,055,000.00 3,363,376,000.00 163,114,000.00 139,347,000.00 23,767,000.00 23,767,000.00 0.00 139,347,000.00 3,200,262,000.00 3,000.00 15,126,000.00 1,062,080,000.00 17,536,000.00 1,044,544,000.00 26,780,000.00 26,780,000.00 2,003,442,000.00 516,328,000.00 15,126,000.00 1,487,114,000.00 3,035,214,000.00 1,797,409,000.00 13,050,000.00 37,215,000.00 55,000,000.00 144,000.00 42,259,000.00 144,000.00 0.00 0.00 884,000.00 884,000.00 1,699,266,000.00 -708,510,000.00 2,407,776,000.00 29,108,000.00 78,100,000.00 1,126,460,000.00 575,127,000.00 598,981,000.00 0.00 1,237,865,000.00 273,881,000.00 147,000.00 19,654,000.00 24,375,000.00 60,040,000.00 219,874,000.00 2,131,000.00 58,356,000.00 55,307,000.00 104,080,000.00 18,578,000.00 190,452,000.00 689,802,000.00 -21,120,000.00 710,922,000.00 14,943,000.00 33,100,000.00 14,943,000.00 14,943,000.00
2022-03-31T00:00:00 annual 32,665,498.00 32,665,498.00 785,579,000.00 1,076,636,000.00 -235,211,000.00 776,643,000.00 -1,865,677,000.00 -235,211,000.00 65,795,000.00 -234,198,000.00 -234,198,000.00 -234,198,000.00 0.00 -234,198,000.00 9,227,000.00 3,277,000.00 -1,837,312,000.00 1,020,881,000.00 326,655,000.00 326,655,000.00 3,759,689,000.00 161,962,000.00 120,658,000.00 41,304,000.00 41,304,000.00 0.00 120,658,000.00 3,597,727,000.00 189,252,000.00 16,863,000.00 1,035,332,000.00 24,491,000.00 1,010,841,000.00 29,690,000.00 29,690,000.00 2,366,575,000.00 571,002,000.00 16,863,000.00 1,795,573,000.00 3,525,491,000.00 1,793,445,000.00 4,811,000.00 37,976,000.00 56,319,000.00 93,000.00 37,704,000.00 93,000.00 0.00 0.00 1,013,000.00 1,013,000.00 1,693,598,000.00 -585,639,000.00 2,279,237,000.00 23,468,000.00 72,052,000.00 1,048,471,000.00 536,264,000.00 598,982,000.00 0.00 1,732,050,000.00 322,511,000.00 0.00 19,654,000.00 26,563,000.00 41,294,000.00 497,291,000.00 2,372,000.00 329,806,000.00 75,161,000.00 89,952,000.00 34,281,000.00 258,412,000.00 627,992,000.00 -22,066,000.00 650,058,000.00 226,563,000.00 1,301,000.00 225,262,000.00 225,262,000.00
2021-03-31T00:00:00 annual 25,015,117.00 25,015,117.00 1,886,768,000.00 2,038,146,000.00 -1,564,711,000.00 424,344,000.00 -2,540,881,000.00 -1,564,711,000.00 51,366,000.00 -1,562,436,000.00 -842,495,000.00 -1,562,436,000.00 0.00 -1,562,436,000.00 3,393,000.00 0.00 -2,660,006,000.00 600,760,000.00 250,151,000.00 250,151,000.00 4,454,200,000.00 900,656,000.00 137,502,000.00 763,154,000.00 43,213,000.00 719,941,000.00 137,502,000.00 3,553,544,000.00 2,000.00 18,500,000.00 1,274,992,000.00 8,153,000.00 1,266,839,000.00 27,521,000.00 27,521,000.00 2,068,064,000.00 730,399,000.00 18,500,000.00 1,337,665,000.00 2,891,764,000.00 1,879,101,000.00 3,935,000.00 34,974,000.00 56,319,000.00 132,000.00 3,819,000.00 132,000.00 0.00 0.00 2,275,000.00 2,275,000.00 1,781,714,000.00 -474,432,000.00 2,256,146,000.00 110,148,000.00 70,195,000.00 1,005,347,000.00 502,133,000.00 568,323,000.00 0.00 1,012,663,000.00 -1,000.00 0.00 37,359,000.00 15,703,000.00 42,883,000.00 248,528,000.00 1,588,000.00 130,577,000.00 26,527,000.00 89,836,000.00 68,779,000.00 153,423,000.00 344,675,000.00 -45,712,000.00 390,387,000.00 101,313,000.00 1,301,000.00 100,012,000.00 100,012,000.00

NSE: WANBURY Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Changes In Cash Financing Cash Flow Interest Paid Cff Net Common Stock Issuance Common Stock Issuance Net Issuance Payments Of Debt Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Net Investment Purchase And Sale Net Intangibles Purchase And Sale Sale Of Intangibles Net PPE Purchase And Sale Sale Of PPE Capital Expenditure Reported Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Stock Based Compensation Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual -134,452,000.00 -486,419,000.00 950,000,000.00 60,400,000.00 -174,234,000.00 34,002,000.00 -1,000.00 14,943,000.00 19,059,000.00 145,531,000.00 -347,057,000.00 60,400,000.00 60,400,000.00 463,581,000.00 463,581,000.00 -486,419,000.00 950,000,000.00 -166,254,000.00 0.00 2,180,000.00 -30,045,000.00 0.00 0.00 35,845,000.00 35,845,000.00 -174,234,000.00 39,782,000.00 -1,827,000.00 -682,303,000.00 -380,881,000.00 -15,396,000.00 50,040,000.00 -140,358,000.00 -205,174,000.00 30,292,000.00 -5,296,000.00 10,819,000.00 130,306,000.00 448,000.00 129,858,000.00 -111,000.00 -2,888,000.00 -2,742,000.00 563,373,000.00
2023-03-31T00:00:00 annual 71,691,000.00 -124,890,000.00 0.00 400,000.00 -126,281,000.00 14,943,000.00 100.00 225,262,000.00 -210,319,000.00 -319,914,000.00 -165,448,000.00 400,000.00 400,000.00 -124,890,000.00 -124,890,000.00 -124,890,000.00 0.00 -88,377,000.00 3,287,000.00 2,692,000.00 3,287,000.00 31,300,000.00 31,300,000.00 625,000.00 625,000.00 -126,281,000.00 197,972,000.00 -1,736,000.00 -67,495,000.00 -91,192,000.00 51,596,000.00 -266,137,000.00 277,418,000.00 -56,195,000.00 212,304,000.00 8,584,000.00 -846,000.00 123,845,000.00 519,000.00 123,326,000.00 -52,000.00 25,623,000.00 612,000.00 -102,868,000.00
2022-03-31T00:00:00 annual 308,652,000.00 -609,389,000.00 0.00 496,625,000.00 -96,577,000.00 225,262,000.00 2,000.00 100,012,000.00 125,248,000.00 -285,846,000.00 -150,755,000.00 496,625,000.00 496,625,000.00 -609,389,000.00 -609,389,000.00 -609,389,000.00 0.00 5,865,000.00 -11,146,000.00 5,607,000.00 -11,146,000.00 0.00 0.00 107,981,000.00 107,981,000.00 -96,577,000.00 405,229,000.00 -1,637,000.00 32,415,000.00 72,217,000.00 -70,338,000.00 566,805,000.00 -248,763,000.00 -283,737,000.00 196,208,000.00 7,110,000.00 -35,798,000.00 114,498,000.00 0.00 114,498,000.00 40,000.00 -233,000.00 6,305,000.00 811,277,000.00
2021-03-31T00:00:00 annual 122,535,000.00 -104,281,000.00 0.00 200,000.00 -44,280,000.00 100,012,000.00 0.00 26,610,000.00 73,402,000.00 -173,854,000.00 -67,619,000.00 200,000.00 200,000.00 -104,281,000.00 -104,281,000.00 -104,281,000.00 0.00 80,441,000.00 120,333,000.00 4,080,000.00 120,333,000.00 0.00 0.00 308,000.00 308,000.00 -44,280,000.00 166,815,000.00 -11,331,000.00 -30,019,000.00 -31,915,000.00 -165,799,000.00 143,187,000.00 -125,955,000.00 135,025,000.00 210,282,000.00 2,030,000.00 -23,502,000.00 97,541,000.00 0.00 97,541,000.00 -64,000.00 6,294,000.00 4,349,000.00 -124,057,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -115,274,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: WANBURY Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Net Non Operating Interest Income Expense Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual 0.00 0.00 72.72 25.83 25.83 55.96 13.03 309.18 98.55 85.52 -28.80 29.18 0.38 30.13 55.96 517.27 0.81 3.31 3.27 0.00 0.00 55.96 55.96 0.00 55.96 55.96 55.96 0.38 56.34 0.02 25.82 -25.83 0.02 -28.80 29.18 0.38 57.21 208.09 64.84 13.03 0.04 12.99 43.65 26.61 17.05 0.81 265.30 309.18 574.48 574.48
2023-03-31T00:00:00 annual -0.19 0.00 24.11 -0.62 -0.62 -10.40 12.38 309.02 23.49 11.11 -20.98 21.39 0.42 -9.96 -10.40 486.31 0.77 3.27 3.27 0.00 0.00 -10.40 -10.40 0.00 -10.40 -10.40 -10.40 0.11 -10.29 0.12 -0.63 0.63 0.00 -20.98 21.39 0.42 11.86 177.29 50.13 12.38 0.05 12.33 34.48 21.24 13.24 0.77 189.15 309.02 498.18 498.18
2022-03-31T00:00:00 annual 0.00 0.00 41.23 71.96 71.96 81.47 11.45 305.87 113.19 101.74 -19.94 20.61 0.67 9.51 81.47 478.09 1.52 3.23 3.22 0.00 0.00 81.47 81.47 0.00 81.47 81.47 81.47 -0.35 81.13 0.42 71.96 -75.84 3.87 -19.94 20.61 0.67 29.14 172.22 44.74 11.45 0.13 11.32 43.66 31.19 12.46 1.52 201.36 305.87 507.24 507.24
2021-03-31T00:00:00 annual -1.08 0.00 24.04 -3.61 -3.61 -12.61 9.75 226.21 20.42 10.67 -22.67 23.07 0.40 -10.08 -12.61 372.37 2.91 2.50 2.50 0.00 0.00 -12.61 -12.61 0.00 -12.61 -12.61 -12.61 0.20 -12.41 0.01 -3.62 0.09 3.53 -22.67 23.07 0.40 14.73 146.16 43.87 9.75 0.21 9.54 30.90 16.69 14.21 2.91 160.89 226.21 387.10 387.10

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
3/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

15.96

P/E

17.664787

P/B

33.039963

Dividend Yield

N/A

Market Cap

923.90 Cr.

Face Value

8.533

Book Value

8.533

ROE

9.33%

EBITDA Growth

68.39 Cr.

Debt/Equity

416.889

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

WANBURY News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

WANBURY News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

WANBURY News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

WANBURY News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

WANBURY News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

WANBURY News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

WANBURY News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

WANBURY News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy wanbury Shares on Fincept?

You can buy Wanbury Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of wanbury?

The market capitalization of Wanbury Limited is ₹924 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Wanbury Limited?

The PE and PB ratios of Wanbury Limited are Not Available and 33.039963 respectively as of 05 Feb 2025.

What is the 52 Week High of Wanbury Limited?

The 52-week high of Wanbury Limited is ₹323.53 as of 05 Feb 2025.

What is the 52 Week Low of Wanbury Limited?

The 52-week low of Wanbury Limited is ₹123 as of 05 Feb 2025.

What are the earnings per share (EPS) for Wanbury Limited?

The Earnings Per Share (EPS) of Wanbury Limited is ₹15.96 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Wanbury Limited?

The Return on Equity (ROE) of Wanbury Limited is 9.33% as per the most recent financial year data. Explore more on Fincept.

JUNIPER

View Stock

THYROCARE

View Stock

IITL

View Stock

JTLIND

View Stock

PRITIKAUTO

View Stock

APEX

View Stock

LOYALTEX

View Stock

ITDC

View Stock

IRMENERGY

View Stock

RATNAVEER

View Stock

ZYDUSLIFE

View Stock

GOKULAGRO

View Stock

VGUARD

View Stock

TRENT

View Stock

BANKBARODA

View Stock